This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arthur E. Baue, MD

Arch Surg. 1992;127(12):1451-1462.

Abstract
• An injury or operation with tissue injury, ischemia, and sepsis provokes a neuroendocrine, immune, and inflammatory response to promote survival and heal the wound. If the injury is massive or complicated by infection, the inflammatory response may become generalized and excessive, producing organ and tissue damage and multiple-organ failure, a modern "horror autotoxicus." Many inflammatory mediators have been identified. In isolated organs, the use of blocking mediators to prevent combined ischemia-reperfusion injury is feasible. With regional ischemia, activator attenuation may be possible. It is unclear whether blockade or modulation of all or part of an excessive inflammatory response will be possible, helpful, and without hazard in patients with multisystem injuries or sepsis. Feedback loops and control mechanisms of these systems will better define such possibilities. Employment of growth factors and other protective agents to stimulate wound healing, infection control, and host resistance may be more helpful. Ultimately, prevention of multiple-organ failure requires sound surgical judgment, techniques, and organ support.

(Arch Surg. 1992;127:1451-1462)

Author Affiliations
From the Department of Surgery, Saint Louis (Mo) University Hospital.

Footnotes
Accepted for publication April 12, 1992.

Reprint requests to 3635 Vista Ave at Grand Blvd, PO Box 15250, St Louis, MO 63110-0250 (Dr Baue).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mediators or Markers of Injury, Inflammation, and Infection (Harbingers of Doom or Predictors of Disaster) and Biologic Puzzles or Ambiguities
Baue
Arch Surg 2007;142:89-93.
FULL TEXT  

Editorial III: Corticosteroids for septic shock--a standard of care?
Bloomfield and Noble
Br J Anaesth 2004;93:178-180.
FULL TEXT  

Presence of the M-type sPLA2 receptor on neutrophils and its role in elastase release and adhesion
Silliman et al.
Am. J. Physiol. Cell Physiol. 2002;283:C1102-C1113.
ABSTRACT | FULL TEXT  

S-Nitroso Human Serum Albumin Treatment Reduces Ischemia/Reperfusion Injury in Skeletal Muscle via Nitric Oxide Release
Hallstrom et al.
Circulation 2002;105:3032-3038.
ABSTRACT | FULL TEXT  

Incidence and Reversibility of Organ Failure in the Course of Sterile or Infected Necrotizing Pancreatitis
Le Mee et al.
Arch Surg 2001;136:1386-1390.
ABSTRACT | FULL TEXT  

Computer Simulation to Study Inflammatory Response
An and Lee
Simulation Gaming 2001;32:344-361.
ABSTRACT  

Is Interleukin 6 an Early Marker of Injury Severity Following Major Trauma in Humans?
Gebhard et al.
Arch Surg 2000;135:291-295.
ABSTRACT | FULL TEXT  

New Mechanisms by Which Secretory Phospholipase A2 Stimulates Neutrophils to Provoke the Release of Cytotoxic Agents
Zallen et al.
Arch Surg 1998;133:1229-1233.
ABSTRACT | FULL TEXT  

High-Volume vs Standard Fluid Therapy in a Septic Pig Model: Impact on Pulmonary Function
Yu et al.
Arch Surg 1997;132:1111-1115.
ABSTRACT  

Multiple Organ Failure, Multiple Organ Dysfunction Syndrome, and Systemic Inflammatory Response Syndrome: Why No Magic Bullets?
Baue
Arch Surg 1997;132:703-707.
ABSTRACT  

Elimination of Various Subpopulations of Macrophages and the Development of Multiple-Organ Dysfunction Syndrome in Mice
Nieuwenhuijzen et al.
Arch Surg 1997;132:533-539.
ABSTRACT  

Limitations of Revascularization in Acute Ischemia-Reperfusion Syndromes
Perry
PERSPECT VASC SURG ENDOVASC THER 1996;9:63-66.